What Цитеал Treats: Main Uses and Benefits

The foaming solution is used for managing symptomatic distress and hygienic control, and may assist with supportive relief in conditions characterized by periods of heightened symptoms.

The preparation is commonly applied in dermatological settings to address superficial skin conditions and dermatoses where microbial overgrowth or secondary infection risk is a significant concern. This involves managing symptoms like localized pruritus (itching), erythema (redness), and persistent malodor. The solution is also relevant for the external hygienic management of accessible mucous membranes, often applied in contexts involving gynecological or perineal symptomatic distress.

Quick Fact: Relief for Localized Irritation

This application is relevant when supportive symptom management is appropriate, assists with maintaining functional stability, and provides supportive relief when symptoms create noticeable physiological strain. It plays a role in managing symptoms related to inflammatory or irritative states, thus contributing to improved comfort during symptomatic periods.

“The preparation is commonly used in clinical settings that involve acute or unstable symptom patterns where temporary assistance in symptom stabilization is important.”

It is often used during phases when symptoms become more noticeable and may be part of symptomatic management in situations involving heightened physiological activity, contributing to easing the overall symptom load.

Regulatory References

1. Base de Données Publique des Médicaments (French Drug Database)

This section outlines the official population eligibility and non-eligibility for Цитеал (a topical antiseptic containing hexamidine and chlorhexidine) strictly based on governmental regulatory documents.

---

Eligibility scope

Populations for whom use is Contraindicated	Eligibility-related Restrictions
Individuals with documented hypersensitivity or allergy to hexamidine or chlorhexidine.	Use is prohibited near the meninges, in the eye, and in the ear canal if the eardrum is perforated.
	Use must be avoided on extensive areas of damaged skin (e.g., large burns) due to the risk of systemic absorption.

Age-related eligibility rules

• Children younger than 2 months of age: Use is not recommended due to the increased risk of skin irritation and systemic absorption.
• Adults and Children 2 months of age and older: Use is allowed, subject to the application site and extent-of-use restrictions.

Pregnancy and lactation eligibility status

• Pregnancy: Use is generally considered acceptable but should be used only if clearly needed and on the advice of a healthcare professional.
• Lactation (Breastfeeding): Use is generally acceptable, but application to the nipples/breasts should be avoided before feeding to prevent infant ingestion.

---

Connection to the overall eligibility profile Regulatory documents define eligibility by establishing absolute contraindications based on known allergies and prohibiting application to specific internal or delicate sites. The profile also sets restrictions and warnings for vulnerable populations, primarily infants and those with compromised skin integrity, due to the recognized risk of systemic absorption of the active ingredients. The medicine is intended solely for external application on eligible patient groups.

Interactions with Other Medicines and Products

The regulatory profile for Цитеал (Chlorhexidine, Hexamidine, Chlorocresol) is defined by its use as a cationic antiseptic for external application. Due to minimal systemic absorption, the official prescribing information does not document any systemic drug–drug interactions, such as those mediated by CYP enzymes or drug transporters, that would alter plasma exposure levels (AUC/Cmax) of the active ingredients.

The primary focus of documented interactions is on chemical incompatibility that affects local efficacy. Co-administration with anionic derivatives is officially a contraindicated combination.

Officially Documented Incompatibility

Interaction Type	Interacting Substance/Class	Official Outcome/Restriction
Pharmacodynamic Neutralization	Anionic derivatives (soaps, common detergents)	Loss of antimicrobial activity; Contraindicated
Local Incompatibility Risk	Other topical antiseptics	Avoid co-administration

This mandatory restriction reflects that anionic substances chemically neutralize the positively charged cationic components. Regulatory text specifies that the skin or mucous membrane must be thoroughly rinsed with water after the use of any soap or anionic product and before the application of Цитеал to eliminate residual anionic agents. No interactions with food, alcohol, or herbal products are documented in the regulatory labels for this external solution.

How Цитеал Works: Pharmacodynamic Mechanism

Цитеал operates via the synergistic, multi-target pharmacodynamic action of its three cationic agents—Chlorhexidine, Hexamidine, and Chlorocresol—which results in the reduction of surface microorganisms. The primary mechanism initiates with the electrostatic binding of these positively charged molecules to the negatively charged lipid bilayer of the microbial cell membrane.

This binding causes the rapid physical disruption and lysis of the cell wall, leading to the leakage of essential internal components like potassium ions. Concurrently, the agents drive a second lethal cascade by interfering with microbial energy pathways. Chlorocresol, notably, facilitates the uncoupling of the Proton Motive Force ( PMF), which effectively halts ATP synthesis and contributes to extensive microbial destruction. Furthermore, Chlorhexidine exhibits substantivity—binding to the skin's keratinized layers to create a localized reservoir—which maintains residual antiseptic activity for a sustained period on the treated surface.

How to Use Цитеал: Official Administration Guidelines

Цитеал is an antiseptic foaming solution whose proper use is defined by guidelines for external hygienic management. As a topical product, dosing is procedural, focusing on preparation, application, and rinsing.

---

Administration Scope and Route

The approved route of administration is the Cutaneous Route, meaning the solution is strictly for external use only on the skin and accessible mucous membranes. The product must not be injected or swallowed.

Instruction	Detail
Route of administration	External/Topical Use Only
Frequency pattern	Typically one to two applications per day.
Course duration	Use is generally episodic, often for a period of 7 to 10 days.
Age-group use	Approved for all ages, but should be used with caution in children.

---

Preparation and Procedural Steps

Цитеал is used like a liquid soap, but requires adherence to specific preparation and cleansing rules:

1. Preparation: The solution may be used pure (undiluted) or diluted at a ratio of 1 volume of solution to 9 volumes of water (a 1/10 dilution). The diluted solution must be prepared immediately before use and cannot be stored.
2. Application: Apply the pure or diluted solution to the affected area of the skin or mucous membrane.
3. Mandatory Rinsing: Following every application, the treated area must be rinsed abundantly with clean water.

---

Administration Constraints

Specific rules exist to maintain the product's efficacy and prevent misuse:

• Incompatibility: The solution must not be used simultaneously with ordinary soap, nor should it be mixed with other antiseptics, as this may reduce its effectiveness.
• Packaging: The container should not be closed with a cork stopper due to incompatibility issues.
• Exclusions: It is not intended for the cleaning of the eyes, ear canal (in case of eardrum perforation), or for the disinfection of medical equipment.

Research Evidence / Overview of Studies for Цитеал

This overview summarizes the available research regarding the clinical evaluation of the active ingredients in Цитеал, focusing only on the types of studies conducted and the patterns observed, as reported by authoritative scientific and regulatory sources.

---

Evidence for Hygienic Management of Superficial Skin Conditions

Research exploring how symptoms change over time has focused on the application of this preparation as a hygienic measure for superficial skin conditions, particularly where microbial growth or the risk of secondary infection is a concern. Studies were observed in patients presenting with conditions where symptoms may vary in intensity. Findings describe patterns observed that confirmed the active ingredients was studied for antimicrobial activity in laboratory settings, indicating activity against various bacteria and fungi. When applied in clinical contexts, studies reported measurements of change in microbial counts on the skin surface.

Evidence for External Hygiene of Accessible Mucous Membranes

Studies examined the use of the preparation for external hygiene in adults requiring cleansing of accessible mucous membranes, particularly in research contexts involving fluctuating or unstable symptoms. Data show patterns related to the product's utility as a supportive hygienic measure when applied in studies examining patient-reported experiences related to localized discomfort. Findings reported measurements of a change in the density of microbial flora during the study period.

Understanding Study Duration and Recognized Uncertainties

Most research for the cleansing and hygienic uses of Цитеал was studied for short-term outcomes. Measures of antimicrobial activity were studied for a short period to assess how long active ingredient presence was monitored on the skin surface after rinsing. Clinical studies typically had treatment periods lasting only a few days up to one week. Long-term effects are not fully established for this antiseptic combination, and the research exploration for sustained or maintenance outcomes is limited. A key limitation is the absence of a large number of Randomized Controlled Trials (RCTs) conducted on this specific three-component, aqueous foaming solution. Consequently, much of the understanding of its potential is extrapolated from extensive research on its individual cationic components.

Key Studies & References

1. Base de Données Publique des Médicaments (Public Drug Database): CITÉAL (69544933)
2. WHO Collaborating Centre for Drug Statistics Methodology: ATC Code D08AC52 (Chlorhexidine in combination with other preparations)

Common questions about Цитеал (FAQ)

Q: Can Цитеал be used for general hygiene purposes, or is it only for specific conditions?

Official regulatory documents describe the product’s function as hygienic management and for infection prevention. The typically defined course of use is for a period of 7 to 10 days. The documentation therefore defines its role as being supportive hygiene for specific periods, rather than long-term general cleansing.

Q: How quickly should the effects of Цитеал be noticeable?

The formulation’s mechanism of action is described as involving the rapid physical disruption of microbial cell membranes upon contact. This action results in the rapid reduction of surface microorganisms according to pharmacological studies.

Q: Can you use Цитеал on the face and neck?

Official guidelines permit application to the skin and accessible mucous membranes. However, regulatory documents strictly prohibit use in the eye or in the ear canal if the eardrum is perforated. These application site restrictions are in place due to the risk of serious visual damage or other adverse reactions.

Q: Is it okay to use Цитеал on a daily basis for an extended period?

The typical recommended course duration for using this preparation is 7 to 10 days. Official labeling also notes that local reactions at the application site, such as tingling or a burning sensation, are reported to occur particularly with repeated use.

Q: Can people with very sensitive skin use Цитеал?

Official regulatory documentation lists several possible adverse reactions that involve the skin, including irritation, dryness, and redness. The product is also strictly contraindicated for anyone with a known hypersensitivity or allergy to its active ingredients.

Q: Does research indicate the effectiveness of Цитеал for post-operative care?

Studies have examined the preparation's utility as a supportive hygienic measure in contexts involving superficial skin conditions. This research is focused on situations where there is a risk of secondary infection.

Q: Is there official information about using Цитеал for conditions like acne or eczema?

The available research has examined the preparation for its use as a hygienic measure for superficial skin conditions in general. These studies focus on situations where a microbial growth concern exists. Specific conditions such as acne or eczema are not listed as official indications in the regulatory documentation.

Q: Does using too much Цитеал increase the risk of side effects?

Regulatory documents advise avoiding use on extensive areas of damaged skin, such as large burns. This restriction is due to the recognized risk of systemic absorption of the active ingredients, which is generally related to the total amount of product applied over a large or compromised area.

Q: Is the foam or lather from Цитеал supposed to be thick?

Official documentation describes the preparation as a foaming solution that is commercially presented as a viscous light-yellow liquid. The viscous quality refers to the thickness of the liquid itself before lathering.

Q: Why is proper rinsing of Цитеал described as an important step?

Rinsing with clean water is required after every application as a procedural step. This requirement is in place to prevent the risk of local reactions and to ensure that residual product is eliminated from the skin surface.

Q: Why is Цитеал often recommended for use before a medical procedure?

The preparation is officially indicated for hygienic management and infection prevention on the skin and accessible mucous membranes. This official purpose is the basis for its utility in pre-procedural cleansing contexts.

Q: What does 'antiseptic' mean in the context of this product?

The preparation is officially classified as an antiseptic, which means it is formulated for effective hygienic management. It utilizes a powerful broad-spectrum antimicrobial activity to reduce microbial load (the number of microorganisms) on the skin and mucous membranes.

Q: Why do some people mistakenly think Цитеал is a classic antibiotic?

Official labeling classifies this preparation as an Antiseptic and Disinfectant that works on the surface of the skin. It is designed to reduce microbial load externally and is not classified as a systemic antibiotic medicine that is absorbed into the bloodstream.

How to Store and Dispose of Цитеал?

The official regulatory documentation strictly defines the storage and disposal requirements for this product.

Storage and Handling Requirements

The product must be kept cool and stored in a well-ventilated location. To maintain stability, it is required to store the medicine away from sources of ignition, including heat, sparks, open flames, or any other hot surfaces. Users must not smoke near the product.

Storage Classification	Requirement
Temperature/Environment	Keep cool; Store in well-ventilated place.
Handling Constraint	Keep away from heat, sparks, and open flames.

Official Disposal Instructions

Disposal must strictly adhere to the documented regulatory guidelines because the product is classified as a hazardous waste. Both the contents and the container must be disposed of in accordance with relevant environmental protection agency guidelines, which typically prohibits discarding the substance in standard household waste or flushing it down the drain.